IRIS
LUGARESI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.280
EU - Europa 10.792
AS - Asia 8.669
SA - Sud America 1.275
Continente sconosciuto - Info sul continente non disponibili 281
AF - Africa 147
OC - Oceania 13
Totale 36.457
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.787
SG - Singapore 3.298
IT - Italia 2.903
CN - Cina 2.477
UA - Ucraina 1.581
IE - Irlanda 1.346
GB - Regno Unito 1.105
TR - Turchia 1.094
BR - Brasile 1.014
RU - Federazione Russa 984
VN - Vietnam 820
FR - Francia 761
SE - Svezia 745
DE - Germania 598
FI - Finlandia 364
IN - India 282
CA - Canada 232
HK - Hong Kong 114
NL - Olanda 114
BD - Bangladesh 113
AR - Argentina 94
JP - Giappone 69
PL - Polonia 62
ZA - Sudafrica 60
MX - Messico 58
KR - Corea 56
ES - Italia 52
IQ - Iraq 48
EC - Ecuador 46
ID - Indonesia 40
IR - Iran 39
CR - Costa Rica 37
IL - Israele 36
AT - Austria 31
JM - Giamaica 29
CO - Colombia 27
CZ - Repubblica Ceca 27
HN - Honduras 26
TT - Trinidad e Tobago 26
CL - Cile 25
BE - Belgio 22
EU - Europa 21
PY - Paraguay 21
PK - Pakistan 20
MA - Marocco 19
NI - Nicaragua 19
SA - Arabia Saudita 19
VE - Venezuela 19
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
LT - Lituania 16
SV - El Salvador 16
GT - Guatemala 15
MY - Malesia 15
UY - Uruguay 15
CW - ???statistics.table.value.countryCode.CW??? 14
AU - Australia 13
CH - Svizzera 13
KE - Kenya 13
NP - Nepal 13
PR - Porto Rico 13
TN - Tunisia 12
EG - Egitto 11
GR - Grecia 11
PH - Filippine 11
DK - Danimarca 10
JO - Giordania 10
RS - Serbia 10
PE - Perù 8
AZ - Azerbaigian 7
ET - Etiopia 7
KZ - Kazakistan 7
BH - Bahrain 6
SC - Seychelles 6
AM - Armenia 5
DO - Repubblica Dominicana 5
GP - Guadalupe 5
HR - Croazia 5
MK - Macedonia 5
RO - Romania 5
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
LB - Libano 4
SY - Repubblica araba siriana 4
AL - Albania 3
BB - Barbados 3
BN - Brunei Darussalam 3
GE - Georgia 3
OM - Oman 3
SN - Senegal 3
TW - Taiwan 3
AO - Angola 2
BS - Bahamas 2
CG - Congo 2
EE - Estonia 2
GD - Grenada 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
Totale 36.172
Salva come PNG Salva come JPEG
Città #
Singapore 2.357
Jacksonville 1.789
San Jose 1.633
Chandler 1.482
Dublin 1.333
Southend 794
Council Bluffs 789
Ashburn 723
Dallas 722
Princeton 617
Izmir 599
Beijing 534
Nanjing 462
Wilmington 351
Ho Chi Minh City 311
Cambridge 302
Santa Clara 289
Los Angeles 286
The Dalles 215
Tongling 205
Altamura 199
Buffalo 199
New York 188
Nanchang 181
Hanoi 168
Milan 162
Rome 161
Dearborn 157
Ann Arbor 150
Moscow 131
Woodbridge 131
Hong Kong 106
Boardman 96
São Paulo 94
Shenyang 93
Jiaxing 88
Houston 87
Hebei 81
Munich 81
Chieti 75
Kunming 74
Tianjin 70
Columbus 66
Redondo Beach 65
Silver Spring 65
Norwalk 64
Phoenix 63
Brooklyn 62
Hefei 60
Montreal 55
North Bergen 55
Bologna 54
Naples 54
Kimball 50
Toronto 50
Florence 48
Grevenbroich 46
Seoul 46
Tokyo 46
Hangzhou 45
Warsaw 45
Atlanta 44
Chicago 43
Changsha 42
Washington 42
San Mateo 39
Torino 39
London 38
Carrboro 37
Helsinki 37
Orem 37
Bari 36
Denver 36
Johannesburg 35
Da Nang 34
Haiphong 34
Turin 34
Dong Ket 33
Frankfurt am Main 33
Stockholm 32
Leawood 30
Ardabil 29
Nuremberg 29
Rio de Janeiro 29
Boston 28
Genoa 28
San Francisco 28
San José 28
Turku 28
Orange 26
Poplar 26
Augusta 25
Seattle 25
Brasília 24
Chennai 24
Jinan 24
Philadelphia 24
Mexico City 23
Pisa 23
Verona 23
Totale 20.833
Salva come PNG Salva come JPEG
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.838
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 508
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 247
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 235
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 229
Un caso di mieloneuropatia da HTLV- I in Italia 223
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 219
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 196
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 183
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 178
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 177
Cleavage of cystatin C is not associated with multiple sclerosis 176
IL 13 in multiple sclerosis 172
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 172
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 171
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 171
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 171
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 167
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 162
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 161
F response in vascular and degenerative upper motor neuron lesions 161
Increasing age at disability milestones among MS patients in the MSBase Registry 160
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 158
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 158
"Minimal" chronic inflammatory demyelinating polyneuropathy 156
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 156
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 154
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 154
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 150
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 150
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 150
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 149
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 148
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 147
Chronic inflammatory demyelinating polyneuropathy in diabetes 145
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 145
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 145
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 145
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 145
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 145
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 144
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 144
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 144
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 144
Effect of TNF intraneural injection into the rat sciatic nerve 143
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 143
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 143
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 143
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 143
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 141
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 140
Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy 140
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 139
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 139
Transdermal scopolamine cycloplegia in juvenile diabetes 139
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 139
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 138
Effect of rhTNF-alpha injection into rat sciatic nerve 137
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 137
Neurite ottica retrobulbare: studio biometrico del nervo ottico 136
Autoimmunity and interferon beta1B 136
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 136
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 136
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 135
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 135
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 135
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 134
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 134
Neurite ottica: relazione tra perimetria, PEV e RMN 133
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 132
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention. 132
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 131
Benign monomelic amyotrophy of lower limb: a rare entity with a characteristic muscular CT 131
JCV-Ab serostatus in MS patients treated with Natalizumab 131
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 131
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 130
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 130
Demyelinating motor Guillain-Barré syndrome following Rubella 130
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 129
Caratteristiche elettrofisiologiche della polineuropatia acuta assonale motoria associata ad elevato titolo di anticorpi anti-GD1a 129
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 129
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 129
Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. 129
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 129
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 128
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 128
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 128
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 127
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 127
Interferone beta: effetti collaterali 127
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 127
HTLV-1-associated myeloneuropathy in an Italian. 127
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 127
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 126
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 126
Effect of rhTNF-a injection into rat sciatic nerve 126
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of an italian cohort of 462 cases 126
TheND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy 125
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 124
A prospective observational study to evaluate the safety and efficacy of serum-free subcutaneous Interferon-Beta 1A in patients with multiple sclerosis in the daily clinical setting, with a focus on injection-site reactions: preliminary results from sale. 124
Totale 16.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.147 0 0 0 193 62 35 42 99 94 27 198 397
2022/20234.212 376 504 192 499 416 851 290 302 488 55 129 110
2023/20241.870 152 105 109 52 84 545 465 75 24 43 37 179
2024/20254.692 342 773 737 77 87 141 117 261 396 243 572 946
2025/202610.315 819 423 1.353 1.475 821 571 1.440 634 1.102 834 657 186
2026/20272.785 219 554 490 1.522 0 0 0 0 0 0 0 0
Totale 36.457